(Q37897445)

25 August 2017

1 reference

title

Quinolone antibacterial agents for the treatment of genitourinary tract infections (English)

1 reference

25 August 2017

0 references

T J Babinchak

1

1 reference

25 August 2017

R J Fass

series ordinal

2

1 reference

25 August 2017

publication date

1 December 1989

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

25 August 2017

published in

1 reference

25 August 2017

volume

8

1 reference

25 August 2017

issue

12

1 reference

25 August 2017

page(s)

1111-1116

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01975178

25 August 2017

exact match

0 references

cites work

The comparative in-vitro activity of pefloxacin.

1 reference

https://api.crossref.org/works/10.1007%2FBF01975178

In vitro activity of ciprofloxacin (Bay o 9867)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975178

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975178

In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975178

Activities of new quinoline derivatives against genital pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975178

In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975178

Norfloxacin penetration into human renal and prostatic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975178

Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975178

Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975178

Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975178

Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975178

Norfloxacin, amoxycillin, cotrimoxazole and nalidixic acid: A summary of 3-day and 7-day therapy studies in the treatment of urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975178

Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975178

Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975178

Randomized, double-blind comparison of ciprofloxacin and trimethoprim-sulfamethoxazole for complicated urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975178

Evaluation of 500- and 1,000-mg doses of ciprofloxacin for the treatment of chancroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975178

Penetration of ciprofloxacin into gynecological tissues following oral and intravenous administration

21 January 2018

1 reference

12 December 2020

Efficacy and safety of a single dose therapy of a 500 mg ciprofloxacin tablet in chancroid patients

1 reference

12 December 2020

Effect of new quinolones on the human gastrointestinal microflora.

1 reference

12 December 2020

Bacterial resistance to fluoroquinolones

1 reference

12 December 2020

Ciprofloxacin in management of urinary tract infection

1 reference

12 December 2020

Open randomised comparison of ofloxacin and norfloxacin in the treatment of complicated urinary tract infections

1 reference

12 December 2020

Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1.

1 reference

12 December 2020

Ciprofloxacin versus ampicillin and probenecid in the treatment of uncomplicated gonorrhoea in men

1 reference

12 December 2020

Clinical evaluation of norfloxacin versus cotrimoxazole in urinary tract infections

1 reference

12 December 2020

Norfloxacin in the treatment of uncomplicated gonococcal infections

1 reference

12 December 2020

Coordinated multicenter study of norfloxacin versus trimethoprim-sulfamethoxazole treatment of symptomatic urinary tract infections. The Urinary Tract Infection Study Group

1 reference

12 December 2020

Single dose ciprofloxacin for treating gonococcal infections in men.

1 reference

12 December 2020

Controlled trial of a short and a prolonged course with ciprofloxacin in patients undergoing transurethral prostatic surgery

1 reference

12 December 2020

Treatment of chancroid with ciprofloxacin. A prospective, randomized clinical trial.

1 reference

12 December 2020

Ciprofloxacin treatment of chlamydial infections of urogenital tracts of women

1 reference

12 December 2020

Penetration of ciprofloxacin into gynecologic tissues

1 reference

12 December 2020

Ofloxacin, a new quinolone for the treatment of gonorrhea

1 reference

12 December 2020

Lack of effectiveness of ofloxacin against experimental syphilis in rabbits

1 reference

12 December 2020

Norfloxacin versus parenteral therapy in the treatment of complicated urinary tract infections and resistant organisms.

1 reference

12 December 2020

Efficacy of norfloxacin in urinary tract infection biological effects on vaginal and fecal flora.

1 reference

12 December 2020

Treatment of chronic bacterial prostatitis with ciprofloxacin. Results of a one-year follow-up study.

1 reference

12 December 2020

Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men.

1 reference

12 December 2020

The comparative in-vitro activity of eight newer quinolones and nalidixic acid.

1 reference

12 December 2020

The comparative pharmacokinetics of five quinolones

1 reference

12 December 2020

Activity of pefloxacin and thirteen other antimicrobial agents in vitro against isolates from hospital and genitourinary infections.

1 reference

12 December 2020

Treatment of acute urinary infection by norfloxacin or nalidixic acid/citrate: a multi-centre comparative study

1 reference

12 December 2020

Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence

1 reference

12 December 2020

Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.

1 reference

12 December 2020

Single doses of ofloxacin in uncomplicated gonorrhoea

1 reference

12 December 2020

Treatment of Penicillin-ResistantNeisseria gonorrhoeaewith Oral Norfloxacin

1 reference

12 December 2020

Norfloxacin versus cotrimoxazole in the treatment of lower urinary tract infections

1 reference

12 December 2020

Treatment of nongonococcal urethritis with ciprofloxacin

1 reference

12 December 2020

Norfloxacin versus cotrimoxazole in the treatment of uncomplicated urinary tract infections--a multi-centre trial

1 reference

12 December 2020

Norfloxacin versus co-trimoxazole for treatment of urinary tract infections in adults: microbiological results of a coordinated multicentre study.

1 reference

12 December 2020

The comparative in-vitro activity of twelve 4-quinolone antimicrobials against Haemophilus ducreyi

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01975178

1 reference

25 August 2017

1 reference